Skip to main content

CVE detail

CVE-2012-2520

Cross-site scripting (XSS) vulnerability in Microsoft InfoPath 2007 SP2 and SP3 and 2010 SP1, Communicator 2007 R2, Lync 2010 and 2010 Attendee, SharePoint Server 2007 SP2 and SP3 and 2010 SP1, Groove Server 2010 SP1, Windows SharePoint Services 3.0 SP2, SharePoint Foundation 2010 SP1, and Office Web Apps 2010 SP1 allows remote attackers to inject arbitrary web script or HTML via a crafted string, aka "HTML Sanitization Vulnerability."

CVSS 4.3 · MediumBuzz score 11.9

Buzz score

Why this CVE is surfacing

Buzz score total 11.9

This all-time snapshot uses the same composite formula as Trending across a 30-year evidence window, rather than a current rolling window.

Buzz score components · mention 6.9 · diversity 5.0 · KEV 0.0 · OTX 0.0 · PoC 0.0
Mention score
6.9
1 evidence mentions in the snapshot
Diversity score
5.0
1 sources across 1 categories
KEV score
0.0
No KEV entry observed
OTX score
0.0
0 OTX pulses
PoC score
0.0
0 repos · best confidence N/A
Best PoC traction
0
Maximum stars on a matched PoC repo

Why it matters now

Mention timeline

Total mentions
0
within the 30d window
Peak daily
0
highest bucket

Evidence

Source links by recency

Newest mentions first
1 source links · newest first
  • Microsoft Patched XSS Flaw After Google Security Researchers Found It Within Hotmail The HTML sanitization flaw patched by Microsoft in this month’s Patch Tuesday appears to have been discovered originally as a cross-site scripting flaw on Microsoft’s Web-based Hotmail email service.

    newswww.securityweek.comOct 11, 2012, 2:51 PM

Exploit code

Public exploit repository references

Public PoC repositories are third-party, potentially unsafe artifacts. Treat their code as untrusted and use it only on authorized systems in an isolated, least-privilege environment. cvebuzz does not execute the code or verify that an exploit works.

0 repository references · best confidence N/A · max 0 stars
No public PoC repositories have been matched yet.

Related records

Similar CVEs

6 related CVEs with shared weakness or product evidence